Genentech: Mike Crowley. Working with gRED and how that makes Genentech Partnering unique. AstraZeneca: Morten Faester & Magnus Bjorsne. Tackling Diabetes from a more holistic perspective Genentech Partnering:Kinney Horn. Kadcyla the first antibody-drug conjugate for treating HER2-positive metastatic breast cancer GSK & Avalon Ventures: Collaborating to invest $495 million in early stage life science companies EMD Serono: Philippe M Lopes-Fernandes. Closure of Geneva site creates opportunities for new business successes TVM Capital: Axel Polack. Investing in developing exciting life science products and companies who aspire to be innovative leaders. AstraZeneca: Morten Faester & Magnus Bjorsne. Tackling Diabetes from a more holistic perspective CIRM: Elona Baum. Funding stem cell research at California institutions